Qiao Wenhui, Yu Feng, Wu Lupeng, Li Bin, Zhou Yanming
Department of General Surgery, First Hospital of Lanzhou University, Lanzhou, China.
Department of Hepatobiliary Surgery, No.101 Hospital of CPLA, Wuxi, China.
BMC Gastroenterol. 2016 Jan 28;16:11. doi: 10.1186/s12876-016-0427-2.
Hepatocellular carcinoma (HCC) with biliary tumor thrombus (BTT) is rare and its impact on postoperative prognosis remains controversial. The aim of this study was to evaluate the published evidence concerning the outcome of surgical resection of HCC with BTT.
Eligible studies were identified by searching PubMed and reviewed systematically. Comparisons of the clinicopathologic features and surgical outcomes for HCC patients with or without BTT were analyzed using meta-analytical techniques.
Twenty retrospective studies containing 598 patients that met the selection criteria were included for review. The perioperative mortality was 2.1 % (range, 0-10 %), and the median 5-year overall survival (OS) was 24 % (range, 0-48 %) with a recurrence rate of 63.9 % (range, 42-91 %). Pooled analysis of 13 comparative studies showed that HCC patients with BTT had a higher incidence of vascular invasion (odds ratio [OR]: 4.70, 95 % CI: 2.90-7.60; P <0.001), a higher frequency of poor differentiation (OR: 2.07, 95 % CI: 1.23-3.49; P = 0.006), and a shorter 5-year OS rate (OR: 0.31, 95 % CI: 0.21-0.64; P <0.001) than those without BTT.
Although HCC with BTT has more aggressive biological characteristics and is an indicator of poor prognosis, surgical resection can still provide long-term survival for some patients.
伴有胆管肿瘤血栓(BTT)的肝细胞癌(HCC)较为罕见,其对术后预后的影响仍存在争议。本研究旨在评估已发表的关于伴有BTT的HCC手术切除结果的证据。
通过检索PubMed确定符合条件的研究并进行系统综述。采用荟萃分析技术分析有或无BTT的HCC患者的临床病理特征和手术结果的比较。
纳入20项回顾性研究,共598例符合选择标准的患者进行综述。围手术期死亡率为2.1%(范围0 - 10%),5年总生存率(OS)中位数为24%(范围0 - 48%),复发率为63.9%(范围42 - 91%)。13项比较研究的汇总分析显示,伴有BTT的HCC患者血管侵犯发生率更高(比值比[OR]:4.70,95%置信区间[CI]:2.90 - 7.60;P < 0.001),低分化频率更高(OR:2.07,95% CI:1.23 - 3.49;P = 0.006),5年OS率低于无BTT的患者(OR:0.31,95% CI:0.21 - 0.64;P < 0.001)。
尽管伴有BTT的HCC具有更具侵袭性的生物学特征且是预后不良的指标,但手术切除仍可为部分患者提供长期生存。